“Two-phase”的搜索结果，显示 141-150 项，共有 4793 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Participants in both Phase 1 and 2 will be selected for treatment with \[177Lu\]Lu FAP 2286 based on \[68Ga\]Ga FAP 2286 imaging for determining tumor FAP ...

3. 血液科- 临床试验- 妙佑医疗国际

   This study includes 2 parts; step-up dose optimization (Part 1) and dose ... phase II dose (RP2D of APG2575 in combination with Pomalidomide ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase I trial evaluates the safety ... 2, a protein needed for cancer cell survival. Giving venetoclax ... A Study to Test the Effectiveness of Two ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... phase 2 dose (RP2D) of APG-2575. Understanding the Relationship Between ... This study consists of two parts to explore BGB-16673 recommended dosing: a part 1 ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary purpose of the phase II study is to estimate the progression-free survival rate at 2 years post-registration to see if treatment is efficacious ...

9. 血液科- 临床试验- 妙佑医疗国际

   This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...

10. 神经科- 临床试验- 妙佑医疗国际

    The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...